At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 82 enrolled
Drug / intervention
Pregabalin 75mg +1 moredrug
Likely dose
Pregabalin 75mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty - A Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Pregabalin 75mg and Pregabalin 150mg for Knee Osteoarthritis. Completed, enrolled 82 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the efficacy of 75 mg of Pregabalin and 150 mg of Pregabalin in postoperative pain control after TKA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesThailand
Collaborators--
Timeline
Phase 4CompletedFinished
20222023202420252026
Enrollment StartJul 2021
First PostedJul 2022
Primary CompletionSep 2023
Study CompletionMar 2024
TodayJul 2026
First PostedJul 7, 2022
Enrollment StartJul 1, 2021
Primary CompletionSep 1, 2023
Study CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 4.0 years ago
Interventions
Pregabalin 75mgdrug
1 tab of Pregabalin Brillior 75 mg and 1 tab of Placebo
Pregabalin 150mgdrug
2 tabs of Pregabalin Brillior 75 mg